CCI has approved an investment by Ranjan Pai, chairman of Manipal Education and Medical Group, in PharmEasy. Pai's investment makes him one of the largest investors in Pharmeasy, with his stake now estimated at more than 12%. As part of this investment, Pai will also acquire three board seats in Pharmeasy's parent company, API Holdings, following the CCI's clearance.